Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy
Coronary Artery Disease
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Progression of CAC was significantly greater in patients receiving statins who had an MI compared with event-free subjects despite similar LDL control. Continued expansion of CAC may indicate failure of some patients to benefit from statin therapy and an increased risk of having cardiovascular events.